Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al

por Skobieranda, Franck, Candler, Shawn, Macfadden, Wayne
Publicado 2022

New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties

por Yu, Chungping, Garcia-Olivares, Jennie, Candler, Shawn, Schwabe, Stefan, Maletic, Vladimir
Publicado 2020

Individualized Treatment Patterns for Patients with Narcolepsy Treated with Oxybate: A Clinical Practice Perspective

por Roy, Asim, Ito, Diane, Morris, Susan, Candler, Shawn, Profant, Judi, Bae, Charles
Publicado 2023

Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary

por Rosenberg, Russell, Braceras, Rogelio, Macfadden, Wayne, Candler, Shawn, Black, Jed, Ruoff, Chad
Publicado 2023

Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status

por Findling, Robert L., Candler, Shawn A., Nasser, Azmi F., Schwabe, Stefan, Yu, Chungping, Garcia-Olivares, Jennie, O’Neal, Welton, Newcorn, Jeffrey H.
Publicado 2021

A Novel Assessment Tool for Impulsive Aggression in Children with Attention-Deficit/Hyperactivity Disorder

por Ceresoli-Borroni, Gianpiera, Liranso, Tesfaye, Brittain, Scott T., Connor, Daniel F., Evans, Christopher J., Findling, Robert L., Hwang, Steve, Candler, Shawn A., Robb, Adelaide S., Nasser, Azmi, Schwabe, Stefan
Publicado 2019